Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Haagsma

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Bailliere'S Clinical Rheumatology|February 1, 1997
Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs)A M van Gestel, C J Haagsma, D E Furst, et al.
British Journal of Rheumatology|December 31, 1997
Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trialC J Haagsma, P L van Riel, A J de Jong, et al.
Annals of the Rheumatic Diseases|December 21, 2004
Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexateM Hoekstra, C J Haagsma, C J A Doelman, et al.
British Journal of Clinical Pharmacology|August 1, 1996
Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical responseC J Haagsma, F G Russel, T B Vree, et al.
British Journal of Rheumatology|April 1, 1995
Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trialA M van Gestel, R F Laan, C J Haagsma, et al.
British Journal of Rheumatology|August 1, 1995
Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritisP Barrera, C J Haagsma, A M Boerbooms, et al.
British Journal of Rheumatology|November 1, 1994
Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapyC J Haagsma, P L van Riel, D J de Rooij, et al.
The Journal of Rheumatology|March 25, 1999
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for RheumatologyA M van Gestel, J J Anderson, P L van Riel, et al.
Annals of the Rheumatic Diseases|May 27, 1999
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritisC J Haagsma, H J Blom, P L van Riel, et al.
Arthritis and Rheumatism|November 17, 2001
The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patientsA E van Ede, R F Laan, H J Blom, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Bailliere'S Clinical Rheumatology|February 1, 1997
Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs)A M van Gestel, C J Haagsma, D E Furst, et al.
British Journal of Rheumatology|December 31, 1997
Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trialC J Haagsma, P L van Riel, A J de Jong, et al.
Annals of the Rheumatic Diseases|December 21, 2004
Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexateM Hoekstra, C J Haagsma, C J A Doelman, et al.
British Journal of Clinical Pharmacology|August 1, 1996
Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical responseC J Haagsma, F G Russel, T B Vree, et al.
British Journal of Rheumatology|April 1, 1995
Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trialA M van Gestel, R F Laan, C J Haagsma, et al.
British Journal of Rheumatology|August 1, 1995
Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritisP Barrera, C J Haagsma, A M Boerbooms, et al.
British Journal of Rheumatology|November 1, 1994
Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapyC J Haagsma, P L van Riel, D J de Rooij, et al.
The Journal of Rheumatology|March 25, 1999
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for RheumatologyA M van Gestel, J J Anderson, P L van Riel, et al.
Annals of the Rheumatic Diseases|May 27, 1999
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritisC J Haagsma, H J Blom, P L van Riel, et al.
Arthritis and Rheumatism|November 17, 2001
The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patientsA E van Ede, R F Laan, H J Blom, et al.
Pageof 3